Search

Search Constraints

You searched for: Author/Creator Hofmeister, Craig C.

Search Results

1. A phase 1 clinical trial of oral eltanexor in patients with relapsed or refractory multiple myeloma. Issue 2 (30th November 2021)

2. A phase 1 study of vorinostat maintenance after autologous transplant in high-risk lymphoma. Issue 4 (April 2015)

3. A phase 1 trial of the HDAC inhibitor AR-42 in patients with multiple myeloma and T- and B-cell lymphomas. Issue 10 (3rd October 2017)

4. Characterization of multiple myeloma vesicles by label‐free relative quantitation. Issue 20 (8th October 2013)

7. Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma. Issue 26 (10th September 2022)

8. Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant. Issue 11 (1st May 2020)

9. Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas. Issue 5 (20th August 2021)

10. Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma. Issue 8 (August 2013)